Sari Pesonen

Sari Pesonen

Company: Valo Therapeutics

Job title: Chief Scientific Officer


Pepticrad: Oncolytic Immunotherapy Approach for Solid Tumors In Combination With Checkpoint Blockade 3:30 pm

PeptiCRAd is a rapidly adaptable and cost-effective therapeutic cancer vaccine platform targeting multiple tumor antigens simultaneously Systemic T-cell mediated antitumor efficacy is synergistic with checkpoint blockade therapy First-in-human Phase 1 clinical trial starting H2/2022.Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.